Dupilumab for Adolescents With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 3, Randomized, Double-Blinded Trial

Dupilumab for Adolescents With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 3, Randomized, Double-Blinded Trial Meeting Abstract

publication date

May 1, 2019

webpage

Web of Science

published in

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT Journal

start page

116

end page

116

volume

17